US Patent Issued to Progenics Pharmaceuticals, EXINI Diagnostics on Sept. 16 for "Systems and methods for artificial intelligence-based image analysis for cancer assessment" (American, Swedish Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,417,533, issued on Sept. 16, was assigned to Progenics Pharmaceuticals Inc. (N. Billerica, Mass.) and EXINI Diagnostics AB (Lund, Sweden).

"Systems and methods for artificial intelligence-based image analysis for cancer assessment" was invented by Aseem Undvall Anand (Queens, N.Y.), Karl Vilhelm Sjostrand (Atlantic Highlands, N.J.) and Jens Filip Andreas Richter (Staffanstorp, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein are systems and methods that provide for automated analysis of medical images to determine a predicted disease status (e.g., prostate cancer status) and/or a value corresponding to predicted risk of the diseas...